+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Apoptosis Assays Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4995340
  • Report
  • February 2020
  • Region: Global
  • 138 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam PLC
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Biotium
  • Danaher Corporation
  • GE Healthcare
  • MORE
The Global Apoptosis Assays Market is expected to grow from USD 3,525.46 Million in 2018 to USD 6,410.34 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.91%.

The positioning of the Global Apoptosis Assays Market vendors in the FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report explores the recent significant developments by the leading vendors and innovation profiles in the Global Apoptosis Assays Market including are Becton, Dickinson and Company, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Thermo Fisher Scientific Inc., Abcam PLC, Bio-Techne Corporation, Biotium, Creative Bioarray (A Part of Creative Dynamics Inc.), Danaher Corporation, GE Healthcare, GeneCopoeia, Inc., Geno Technology, Inc., and Sartorius AG.

On the basis of Product, the Global Apoptosis Assays Market is examined across Assay Kits, Instruments, Microplates, and Reagents.

On the basis of Detection Technology, the Global Apoptosis Assays Market is examined across Cell Imaging and Microscopy, Flow Cytometry, and Spectrophotometry.

On the basis of Application , the Global Apoptosis Assays Market is examined across Basic Research, Clinical and Diagnostic Applications, Drug Discovery and Development, and Stem Cell Research.

On the basis of End User, the Global Apoptosis Assays Market is examined across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Apoptosis Assays Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Apoptosis Assays Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Apoptosis Assays Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Apoptosis Assays Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Apoptosis Assays Market

The report answers questions such as:

1. What is the market size of the global Apoptosis Assays market?
2. What are the factors that affect the growth in the Global Apoptosis Assays Market over the forecast period?
3. What is the competitive position in the Global Apoptosis Assays Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Apoptosis Assays Market?
5. What are the opportunities in the Global Apoptosis Assays Market?
6. What are the modes of entering the Global Apoptosis Assays Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcam PLC
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Biotium
  • Danaher Corporation
  • GE Healthcare
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology

3. Executive Summary
3.1. Market Outlook
3.2. Market Data Feed

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porters Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Client Customizations

5. Global Apoptosis Assays Market, by Product
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Assay Kits
5.3.1. Annexin V and Cell Permeability Assays
5.3.2. Caspase assays
5.3.3. DNA Fragmentation Assays
5.3.4. Mitochondrial Assays
5.4. Instruments
5.5. Microplates
5.6. Reagents

6. Global Apoptosis Assays Market, by Detection Technology
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Cell Imaging and Microscopy
6.4. Flow Cytometry
6.5. Spectrophotometry

7. Global Apoptosis Assays Market, by Application
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Basic Research
7.4. Clinical and Diagnostic Applications
7.5. Drug Discovery and Development
7.6. Stem Cell Research

8. Global Apoptosis Assays Market, by End User
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Academic & Research Institutes
8.4. Hospital & Diagnostic Laboratories
8.5. Pharmaceutical & Biotechnology Companies

9. Global Apoptosis Assays Market, by Geography
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Argentina
9.3.2. Brazil
9.3.3. Canada
9.3.4. Chile
9.3.5. Mexico
9.3.6. United States
9.4. Asia-Pacific
9.4.1. Australia
9.4.2. China
9.4.3. India
9.4.4. Indonesia
9.4.5. Japan
9.4.6. Malaysia
9.4.7. Philippines
9.4.8. South Korea
9.4.9. Thailand
9.5. Europe, Middle East & Africa
9.5.1. Denmark
9.5.2. France
9.5.3. Germany
9.5.4. Italy
9.5.5. Netherlands
9.5.6. Qatar
9.5.7. Russia
9.5.8. Saudi Arabia
9.5.9. South Africa
9.5.10. Spain
9.5.11. United Arab Emirates
9.5.12. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.1.1. Forefront
10.1.1.2. Pathfinders
10.1.1.3. Niche
10.1.1.4. Vital
10.1.2. Business Strategy
10.1.2.1. Business Growth
10.1.2.2. Industry Coverage
10.1.2.3. Financial Viability
10.1.2.4. Channel Support
10.1.3. Product Satisfaction
10.1.3.1. Value for Money
10.1.3.2. Ease of Use
10.1.3.3. Product Features
10.1.3.4. Customer Support
10.2. Market Vendor Ranking Analysis
10.3. Competitive News Feed Analysis

11. Company Usability Profiles
11.1. Becton, Dickinson and Company
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Bio-Rad Laboratories
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Merck KGaA
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Promega Corporation
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Thermo Fisher Scientific Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Abcam PLC
11.7. Bio-Techne Corporation
11.8. Biotium
11.9. Creative Bioarray (A Part of Creative Dynamics Inc.)
11.10. Danaher Corporation
11.11. GE Healthcare
11.12. GeneCopoeia, Inc.
11.13. Geno Technology, Inc.
11.14. Sartorius AG

12. Appendix
12.1. Discussion Guide
12.2. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Merck KGaA
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Abcam PLC
  • Bio-Techne Corporation
  • Biotium
  • Creative Bioarray (A Part of Creative Dynamics Inc.)
  • Danaher Corporation
  • GE Healthcare
  • GeneCopoeia, Inc.
  • Geno Technology, Inc.
  • Sartorius AG
Note: Product cover images may vary from those shown
Adroll
adroll